332 related articles for article (PubMed ID: 11566136)
1. Crystal structure of beta-arrestin at 1.9 A: possible mechanism of receptor binding and membrane Translocation.
Han M; Gurevich VV; Vishnivetskiy SA; Sigler PB; Schubert C
Structure; 2001 Sep; 9(9):869-80. PubMed ID: 11566136
[TBL] [Abstract][Full Text] [Related]
2. The 2.8 A crystal structure of visual arrestin: a model for arrestin's regulation.
Hirsch JA; Schubert C; Gurevich VV; Sigler PB
Cell; 1999 Apr; 97(2):257-69. PubMed ID: 10219246
[TBL] [Abstract][Full Text] [Related]
3. An additional phosphate-binding element in arrestin molecule. Implications for the mechanism of arrestin activation.
Vishnivetskiy SA; Schubert C; Climaco GC; Gurevich YV; Velez MG; Gurevich VV
J Biol Chem; 2000 Dec; 275(52):41049-57. PubMed ID: 11024026
[TBL] [Abstract][Full Text] [Related]
4. Activation-dependent conformational changes in {beta}-arrestin 2.
Xiao K; Shenoy SK; Nobles K; Lefkowitz RJ
J Biol Chem; 2004 Dec; 279(53):55744-53. PubMed ID: 15501822
[TBL] [Abstract][Full Text] [Related]
5. 1H NMR structural and functional characterisation of a cAMP-specific phosphodiesterase-4D5 (PDE4D5) N-terminal region peptide that disrupts PDE4D5 interaction with the signalling scaffold proteins, beta-arrestin and RACK1.
Smith KJ; Baillie GS; Hyde EI; Li X; Houslay TM; McCahill A; Dunlop AJ; Bolger GB; Klussmann E; Adams DR; Houslay MD
Cell Signal; 2007 Dec; 19(12):2612-24. PubMed ID: 17900862
[TBL] [Abstract][Full Text] [Related]
6. Structure of active β-arrestin-1 bound to a G-protein-coupled receptor phosphopeptide.
Shukla AK; Manglik A; Kruse AC; Xiao K; Reis RI; Tseng WC; Staus DP; Hilger D; Uysal S; Huang LY; Paduch M; Tripathi-Shukla P; Koide A; Koide S; Weis WI; Kossiakoff AA; Kobilka BK; Lefkowitz RJ
Nature; 2013 May; 497(7447):137-41. PubMed ID: 23604254
[TBL] [Abstract][Full Text] [Related]
7. Crystal structure of pre-activated arrestin p44.
Kim YJ; Hofmann KP; Ernst OP; Scheerer P; Choe HW; Sommer ME
Nature; 2013 May; 497(7447):142-6. PubMed ID: 23604253
[TBL] [Abstract][Full Text] [Related]
8. Helix I of beta-arrestin is involved in postendocytic trafficking but is not required for membrane translocation, receptor binding, and internalization.
Dinh DT; Qian H; Seeber R; Lim E; Pfleger K; Eidne KA; Thomas WG
Mol Pharmacol; 2005 Feb; 67(2):375-82. PubMed ID: 15523053
[TBL] [Abstract][Full Text] [Related]
9. Crystal structure of cone arrestin at 2.3A: evolution of receptor specificity.
Sutton RB; Vishnivetskiy SA; Robert J; Hanson SM; Raman D; Knox BE; Kono M; Navarro J; Gurevich VV
J Mol Biol; 2005 Dec; 354(5):1069-80. PubMed ID: 16289201
[TBL] [Abstract][Full Text] [Related]
10. A phosphorylation cluster of five serine and threonine residues in the C-terminus of the follicle-stimulating hormone receptor is important for desensitization but not for beta-arrestin-mediated ERK activation.
Kara E; Crépieux P; Gauthier C; Martinat N; Piketty V; Guillou F; Reiter E
Mol Endocrinol; 2006 Nov; 20(11):3014-26. PubMed ID: 16887887
[TBL] [Abstract][Full Text] [Related]
11. Beta-arrestin-dependent formation of beta2 adrenergic receptor-Src protein kinase complexes.
Luttrell LM; Ferguson SS; Daaka Y; Miller WE; Maudsley S; Della Rocca GJ; Lin F; Kawakatsu H; Owada K; Luttrell DK; Caron MG; Lefkowitz RJ
Science; 1999 Jan; 283(5402):655-61. PubMed ID: 9924018
[TBL] [Abstract][Full Text] [Related]
12. Arrestin function in G protein-coupled receptor endocytosis requires phosphoinositide binding.
Gaidarov I; Krupnick JG; Falck JR; Benovic JL; Keen JH
EMBO J; 1999 Feb; 18(4):871-81. PubMed ID: 10022830
[TBL] [Abstract][Full Text] [Related]
13. Receptor sequestration in response to β-arrestin-2 phosphorylation by ERK1/2 governs steady-state levels of GPCR cell-surface expression.
Paradis JS; Ly S; Blondel-Tepaz É; Galan JA; Beautrait A; Scott MG; Enslen H; Marullo S; Roux PP; Bouvier M
Proc Natl Acad Sci U S A; 2015 Sep; 112(37):E5160-8. PubMed ID: 26324936
[TBL] [Abstract][Full Text] [Related]
14. Scaffolding functions of arrestin-2 revealed by crystal structure and mutagenesis.
Milano SK; Pace HC; Kim YM; Brenner C; Benovic JL
Biochemistry; 2002 Mar; 41(10):3321-8. PubMed ID: 11876640
[TBL] [Abstract][Full Text] [Related]
15. β-Arrestin biosensors reveal a rapid, receptor-dependent activation/deactivation cycle.
Nuber S; Zabel U; Lorenz K; Nuber A; Milligan G; Tobin AB; Lohse MJ; Hoffmann C
Nature; 2016 Mar; 531(7596):661-4. PubMed ID: 27007855
[TBL] [Abstract][Full Text] [Related]
16. Crystal structure of arrestin-3 reveals the basis of the difference in receptor binding between two non-visual subtypes.
Zhan X; Gimenez LE; Gurevich VV; Spiller BW
J Mol Biol; 2011 Feb; 406(3):467-78. PubMed ID: 21215759
[TBL] [Abstract][Full Text] [Related]
17. Beta-arrestin binding to CC chemokine receptor 5 requires multiple C-terminal receptor phosphorylation sites and involves a conserved Asp-Arg-Tyr sequence motif.
Huttenrauch F; Nitzki A; Lin FT; Höning S; Oppermann M
J Biol Chem; 2002 Aug; 277(34):30769-77. PubMed ID: 12065593
[TBL] [Abstract][Full Text] [Related]
18. Beta-arrestin signaling and regulation of transcription.
Ma L; Pei G
J Cell Sci; 2007 Jan; 120(Pt 2):213-8. PubMed ID: 17215450
[TBL] [Abstract][Full Text] [Related]
19. Arrestin/clathrin interaction. Localization of the arrestin binding locus to the clathrin terminal domain.
Goodman OB; Krupnick JG; Gurevich VV; Benovic JL; Keen JH
J Biol Chem; 1997 Jun; 272(23):15017-22. PubMed ID: 9169477
[TBL] [Abstract][Full Text] [Related]
20. Receptor/beta-arrestin complex formation and the differential trafficking and resensitization of beta2-adrenergic and angiotensin II type 1A receptors.
Anborgh PH; Seachrist JL; Dale LB; Ferguson SS
Mol Endocrinol; 2000 Dec; 14(12):2040-53. PubMed ID: 11117533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
